Value of Literature Review to Inform Development and Use of Biologics in Juvenile Idiopathic Arthritis

Value of Literature Review to Inform Development and Use of Biologics in Juvenile Idiopathic Arthritis

BackgroundJuvenile idiopathic arthritis (JIA) is one of the most common pediatric inflammatory rheumatic diseases (PiRDs). Uncontrolled disease activity is associated with decreased quality of life and chronic morbidity. Biologic disease-modifying antirheumatic drugs (bDMARDs) and Janus kinase inhib...

Full description

Bibliographic Details
Main Authors:	Klervi Golhen, Carolyn Winskill, Cynthia Yeh, Nancy Zhang, Tatjana Welzel, Marc Pfister
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-06-01
Series:	Frontiers in Pediatrics
Subjects:	randomized controlled trials systematic review efficacy safety juvenile idiopathic arthritis bDMARDs
Online Access:	https://www.frontiersin.org/articles/10.3389/fped.2022.909118/full

Similar Items

Tocilizumab in Juvenile Idiopathic Arthritis Associated Uveitis, a Narrative Review
by: Claudia Iannone, et al.
Published: (2023-02-01)

Influence of the timing of biological treatment initiation on Juvenile Idiopathic Arthritis long-term outcomes
by: Filipa Oliveira Ramos, et al.
Published: (2023-09-01)

Risk of infection and disease activity of patients with juvenile idiopathic arthritis treated with and without biologics
by: S. Bouayad, et al.
Published: (2022-03-01)

Spectrum of Clinical Research in Juvenile Idiopathic Arthritis: A Cross-Sectional Analysis of Registered Studies in Clinicaltrials.gov and Clinicaltrialsregister.eu
by: Ronny Lehmann, et al.
Published: (2021-12-01)

Tapering of biological treatment in autoinflammatory diseases: a scoping review
by: Tatjana Welzel, et al.
Published: (2022-08-01)

Impact of multimorbidity on the first ts/bDMARD effectiveness and retention rate after two years of follow-up in patients with rheumatoid arthritis from the BIOBADASER registry
by: Jerusalem Calvo-Gutiérrez, et al.
Published: (2024-02-01)

Risk of cancer for patients with rheumatoid arthritis versus general population: a national claims database cohort studyResearch in context
by: Maxime Beydon, et al.
Published: (2023-12-01)

Biological treatment and exercise as an alternative to typical rheumatoid arthritis therapy: pathophysiology and effects
by: Artur Aghadi, et al.
Published: (2023-02-01)

Understanding efficacy-safety balance of biologics in moderate-to-severe pediatric psoriasis
by: Klervi Golhen, et al.
Published: (2022-09-01)

Biologic Drugs for Rheumatoid Arthritis in the Context of Biosimilars, Genetics, Epigenetics and COVID-19 Treatment
by: Krzysztof Bonek, et al.
Published: (2021-02-01)

Analysis of survival rate and persistence predictors of baricitinib in real-world data from a large cohort of rheumatoid arthritis patients
by: Simone Parisi, et al.
Published: (2024-01-01)

Prediction of ineffectiveness of biological drugs using machine learning and explainable AI methods: data from the Austrian Biological Registry BioReg
by: Dubravka Ukalovic, et al.
Published: (2024-02-01)

The RA-BE-REAL Multinational, Prospective, Observational Study in Patients with Rheumatoid Arthritis Receiving Baricitinib, Targeted Synthetic, or Biologic Disease-Modifying Therapies: a 6-Month Interim Analysis
by: Rieke Alten, et al.
Published: (2022-10-01)

Cytokine Signatures in Psoriatic Arthritis Patients Indicate Different Phenotypic Traits Comparing Responders and Non-Responders of IL-17A and TNFα Inhibitors
by: Marie Skougaard, et al.
Published: (2023-03-01)

Uveitis in patients with oligoarticular juvenile idiopathic arthritis and juvenile spondyloarthritis/enthesitis related arthritis: is there any difference?
by: A. Martins, et al.
Published: (2023-05-01)

Vitamin D and juvenile idiopathic arthritis
by: Sarah L. Finch, et al.
Published: (2018-05-01)

Safety of the COVID-19 vaccination in children with juvenile idiopathic arthritis—A observational study from two pediatric rheumatology centres in Poland
by: Violetta Opoka-Winiarska, et al.
Published: (2023-03-01)

Juvenile Idiopathic Arthritis and Exercise
by: Pınar Kısacık, et al.
Published: (2016-04-01)

Treatment of Juvenile Idiopathic Arthritis-Associated Uveitis
by: İlknur Tuğal-Tutkun
Published: (2016-04-01)

EXPERIENCE WITH ABATACEPT IN TREATMENT OF JUVENILE IDIOPATHIC ARTHRITIS
by: Margarita Fedorovna Dubko, et al.
Published: (2012-10-01)

Juvenile idiopathic arthritis – classification and methods of treatment
by: Weronika Pawłocik, et al.
Published: (2023-04-01)

The necessity, efficacy and safety of biologics in juvenile idiopathic arthritis
by: Mustafa Cakan, et al.
Published: (2020-03-01)

Changes in Inflammatory Cytokines in Responders and Non-Responders to TNFα Inhibitor and IL-17A Inhibitor: A Study Examining Psoriatic Arthritis Patients
by: Marie Skougaard, et al.
Published: (2024-03-01)

Compared efficacy of rituximab, abatacept, and tocilizumab in patients with rheumatoid arthritis refractory to methotrexate or TNF inhibitors agents: a systematic review and network meta-analysis
by: Alisson Pugliesi, et al.
Published: (2023-07-01)

The Impact of Epstein-Barr Virus Infection on Juvenile Idiopathic Arthritis Activity and Patient’s Response to Treatment
by: Violetta Opoka-Winiarska, et al.
Published: (2020-10-01)

Specific Features of Juvenile Idiopathic Arthritis Patients’ Cytokine Profile
by: Daria I. Kozlova, et al.
Published: (2024-01-01)

Analysis of juvenile idiopathic arthritis associated uveitis in India over the last 16 years
by: Sudharshan S, et al.
Published: (2007-01-01)

Causes of invalidity in patients with juvenile idiopathic arthritis
by: T A Slielepina
Published: (2005-04-01)

Differences between leukemic arthritis and juvenile idiopathic arthritis
by: Alfonso Ragnar Torres Jimenez, et al.
Published: (2023-05-01)

Impact of access to treatment on patient‐reported outcomes among rheumatoid arthritis patients with tDMARDs and bDMARDS in two Latin‐American countries: A prospective observational study
by: Juan M. Reyes, et al.
Published: (2023-03-01)

Autosomal Recessive Agammaglobulinemia in Juvenile Idiopathic Arthritis: A Case Report
by: Azadeh Zare Feizabadi, et al.
Published: (2020-06-01)

Stopping bDMARDs at the beginning of pregnancy is associated with disease flares and preterm delivery in women with rheumatoid arthritis
by: Maria Chiara Gerardi, et al.
Published: (2022-08-01)

Differences of hip involvement in systemic and non-systemic juvenile idiopathic arthritis
by: L. S. Sorokina, et al.
Published: (2022-03-01)

Ankle Magnetic Resonance Imaging in Juvenile Idiopathic Arthritis Versus Non-Juvenile Idiopathic Arthritis Patients with Arthralgia
by: Monika Ostrowska, et al.
Published: (2022-01-01)

Juvenile Idiopathic Arthritis Associated Uveitis
by: Emil Carlsson, et al.
Published: (2021-07-01)

Juvenile Idiopathic Arthritis
by: Kenan Barut, et al.
Published: (2017-04-01)

Serum lubricin levels in patients with juvenile idiopathic arthritis
by: Rabia Miray Kisla Ekinci, et al.
Published: (2021-12-01)

Glomerular filtration rate in children with juvenile idiopathic arthritis
by: T.P. Borysova, et al.
Published: (2022-03-01)

Signals and Mechanisms Regulating Monocyte and Macrophage Activation in the Pathogenesis of Juvenile Idiopathic Arthritis
by: Chao-Yi Wu, et al.
Published: (2021-07-01)

A new paradigm of physical development disorder in patients with juvenile idiopathic arthritis
by: T.V. Marushko, et al.
Published: (2020-04-01)